Accessibility Page Navigation
Style sheets must be enabled to view this page as it was intended.
The Royal College of Psychiatrists Improving the lives of people with mental illness

POMH-UK

 

Publication list 


 

News

 

Papers in peer reviewed journals


2014

Paton C, Barnes TRE. Undertaking clinical audit, with reference to a Prescribing Observatory for Mental Health audit of lithium monitoring. The Psychiatric Bulletin, 2014, February.

 

2013

Paton C, Adroer R, Barnes TRE. Monitoring lithium therapy: the impact of a quality improvement programme in the UK. Bipolar Disorder 2013, 15: 865-875.

 

2012

Barnes TRE, Banerjee S, Collins N, Treloar A, McIntyre S, Paton C. Antipsychotics in dementia: prevalence and quality of antipsychotic drug prescribing in UK mental health services. British Journal of Psychiatry, 2012, 201:221-226.

 

Barnes TRE, Drake MJ, Paton C. Nocturnal enuresis with antipsychotic medication. Editorial. British Journal of Psychiatry. 2012;200:7-9.

Barnes TRE, Paton C. Role of the Prescribing Observatory for Mental Health. British Journal of Psychiatry. 2012, 201; 428-429.

Price O, Baker J, Paton C, Barnes TRE. Patient Group Directions: a safe and effective practice? British Journal of Nursing. 2012, 21: 26-31.

 

2011

Barnes TRE, Paton C. Antipsychotic polypharmacy in schizophrenia: benefits and risks. CNS Drugs 2011. 25 (5): 383-399.

 

Barnes TRE, Paton C. Improving prescribing practice in psychiatry: The experience of the Prescribing Observatory for Mental Health (POMH-UK). International Review of Psychiatry. 2011, 23: 328-335.

 

Barnes TRE, Paton C. Uncertainties page: Do antidepressants improve negative symptoms in schizophrenia? BMJ 2011, 342; d3371.

 

Paton C, Flynn A, Shingleton-Smith A, McIntyre S, Bhaumik S, Rasmussen J, Hardy S, Barnes TRE. Nature and quality of antipsychotic prescribing practice in UK psychiatry of learning disability services: findings of a national audit. Journal of Intellectual Disability Research. 2011. 55; 665-674.

 

Paton C, McIntyre S, Bhatti SF, Shingleton-Smith A, Gray R, Gerrett D, Barnes TRE. Medicines reconciliation on admission to inpatient psychiatric care; findings from a UK quality improvement programme. Therapeutic Advances in Psychopharmacology. 2011, 4; 101-110.

 

Shingleton-Smith A, Paton C, Barnes TRE. Antipsychotics: combined and high dose. In, 101 Recipes for Audit in Psychiatry. Edited by C Oakley, et al. 2011, 185-186.

 

2010

Barnes TRE, Paton C. Medication recommendations in the updated NICE guideline for the treatment and management of schizophrenia. Die Psychiatrie 2010, 7;18-24.

 

Collins N, Barnes TR, Shingleton-Smith A, Gerrett D, Paton C. Standards of lithium monitoring in mental health trusts in the UK. BMC Psychiatry 2010;10:80.

 

Gerrett D, Lamont T, Paton C, Barnes TRE, Shah A. Prescribing and monitoring lithium therapy: summary of a safety report from the National Patient Safety Agency. BMJ 2010. 341: c6258.

 

Paton C, Barnes TRE, Shingleton-Smith A, McAllister-Williams RH, Kirkbride J, Jones P, McIntyre S. Lithium in bipolar and other affective disorders: prescribing practice in the UK. Journal of Psychopharmacology 2010;24:1739-1746.

 

Pope A, Adams C, Paton C, Weaver T, Barnes TRE. Assessment of adverse effects in clinical studies of antipsychotic medication: survey of methods used. British Journal of Psychiatry 2010. 197; 67-72.

 

2009

Barnes TRE, Shingleton-Smith A, Paton C. Antipsychotic long-acting injections: prescribing practice in the UK. British Journal of Psychiatry 2009. 195 (Suppl); 37-42.

 

James L, Paton C, Lelliott P, Barnes TRE, Taylor D. Mood stabilisers and teratogenicity – prescribing practice and awareness amongst practicing psychiatrists. Journal of Mental Health 2009. 18; 137-143.

 

Perecherla S, Paton C, Shingleton-Smith A, Barnes TRE. Variations in prescribing patterns for anti-dementia drugs across PCT populations. Progress in Neurology and Psychiatry 2009, vol 13, issue 4; 30-33.

 

2008

Barnes TRE, Paton C, Hancock E, Cavanagh MR, Taylor D, Lelliott P, on behalf of the UK Prescribing Observatory for Mental Health. Screening for the metabolic syndrome in community psychiatric patients prescribed antipsychotics: a quality improvement programme. Acta Psychiatr Scand 2008, 118; 26-33.

 

Paton C, Barnes TRE, Cavanagh MR, Taylor D, Lelliott P. High-dose and combination antipsychotic prescribing in acute adult wards in the UK: the challenges posed by PRN prescribing. British Journal of Psychiatry 2008. 192; 435-439.

 

2007

Barnes TRE, Paton C, Cavanagh M, Hancock E, Taylor DM. A UK audit of screening for the metabolic side effects of antipsychotics in community patients. Schizophrenia Bulletin 200., 33; 1397-1403.

 

James L, Barnes TRE, Lelliott P, Taylor D, Paton C. Informing patients of the teratogenic potential of mood stabilizing drugs: a case note review of the practice of psychiatrists. Journal of Psychopharmacology 2007. 21; 815-819.

 

Paton C, Whittington C, Barnes TRE. Augmentation with a second antipsychotic in patients with schizophrenia who partially respond to clozapine; a meta-analysis. Journal of Clinical Psychopharmacology 2007. 27; 198-204.

 

 

Conference presentations and posters


Barnes TRE. Towards collaborative intervention that improves the lives of patients with schizophrenia: clinicians as drivers of policy change. 22nd European Congress of Psychiatry, 1-4 March 2014, Munich.  

Pope A, Paton C, Shingleton-Smith A, McIntyre S, Hancock E, Baker J, Haddad P, Barnes TRE. The quality of side effect monitoring in people prescribed long-acting antipsychotic injections. BAP summer meeting 26-29 July 2009, Oxford.

Paton C, Barnes TRE, Shingleton-Smith A, McAllister-Williams H, McIntyre S on behalf of the POMH-UK project team. Prescribing patterns with lithium in unipolar depression and bipolar disorder. BAP summer meeting 26-29 July 2009, Oxford.

Pope A. ‘Methods Used to Assess Adverse Effects in a Sample of Reports of Clinical Studies of Antipsychotic Medication’. International Congress of Schizophrenia Research, San Diego, 30 March 2009.

 

Adams S, Barnes TRE, Paton C, Inglis G. 'Benchmarking Prescribing Practice'.  Annual Meeting of the Royal College of Psychiatrists, Imperial College, London, 1-4 July 2008.

 

Paton C, Barnes TRE, Brooke D, Petch E, Shingleton-Smith A.  Prevalence of, and rationale for, the prescription of high-dose and combined antipsychotics in forensic settings in the UK.  Journal of Psychopharmacology 2008, Abstract suppl to vol 22. A44.

Barnes TRE, Paton C, Cavanagh MR, Hancock E, Taylor DM, Lelliott P on behalf of the POMH-UK project team.  A UK audit of screening for the metabolic syndrome in community psychiatric patients prescribed antipsychotics.  BAP summer meeting 2007.  Journal of Psychopharmacology 2007, Abstract suppl to vol 21; TD 21. A61.

Paton C.  Current issues in psychopharmacology.  Maudsley Mediterranean Forum, Palermo, Sicily, 21-24th October 2007.

 

Paton C, Barnes TRE, Cavanagh M, Lelliott P, Taylor D, on behalf of the POMH-UK project team.  Findings of a quality improvement project on the prescription of high-dose and combined antipsychotics for acute adult psychiatric patients.  BAP summer meeting 2007. Journal of Psychopharmacology 2007, Abstract suppl to vol 21; TD 19. A61.

Barnes TRE, Paton C, Hancock E, Cavanagh M, Taylor D, Lelliott P, and the POMH-UK project team. Screening for the metabolic syndrome in people receiving antipsychotic medication in assertive outreach teams: Results of the POMH-UK baseline audit (abstract). ICOSR, Broadmoor, Colorado, March 2007. Schizophrenia Bulletin 2007; 33:494.

Paton C, Barnes TRE, Lelliott P, Taylor D. Prescribing audit of high dose and combined antipsychotics for patients on adult acute and psychiatric intensive care wards.  BAP summer meeting 2006.  Journal of Psychopharmacology 2006, Abstract suppl to vol 20; A22.

Paton C, Whittington C, Barnes TRE.  Augmentation of clozapine with a second antipsychotic for treatment resistant schizophrenia: a meta-analysis.  BAP summer meeting 2006. Journal of Psychopharmacology 2006, Abstract suppl to vol 20; A22.

 

Other

Prescribing antipsychotics for people with dementia

POMH-UK features in MHRA Drug Safety Update


                                                                                                                                                 

 

Back to top

 

 

 

 

Where next...


Where next

 

POMH-UK, 21 Prescot Street, London, E1 8BB    

Tel: 020 3701 2686   Email: pomh-uk@rcpsych.ac.uk

 

Login
Make a Donation